Wells Fargo
AURA icon

Wells Fargo’s Aura Biosciences AURA Stock Holding History

Wells Fargo’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Sell
16,994
-32,059
-65% -$184K ﹤0.01% 5036
2025
Q4 		$267K Buy
49,053
+17,342
+55% +$103K ﹤0.01% 4904
2025
Q3 		$196K Buy
31,711
+8,962
+39% +$58.6K ﹤0.01% 4942
2025
Q2 		$142K Sell
22,749
-5,490
-19% -$32.1K ﹤0.01% 4974
2025
Q1 		$165K Buy
28,239
+616
+2% +$4.66K ﹤0.01% 4826
2024
Q4 		$227K Buy
27,623
+5,930
+27% +$55.8K ﹤0.01% 4723
2024
Q3 		$193K Buy
21,693
+914
+4% +$7.84K ﹤0.01% 4603
2024
Q2 		$157K Buy
20,779
+7,764
+60% +$56.9K ﹤0.01% 4665
2024
Q1 		$102K Buy
13,015
+4,399
+51% +$36.5K ﹤0.01% 4887
2023
Q4 		$76.3K Buy
8,616
+1,841
+27% +$15.6K ﹤0.01% 5073
2023
Q3 		$60.8K Sell
6,775
-3,655
-35% -$39.3K ﹤0.01% 5076
2023
Q2 		$129K Buy
10,430
+5,869
+129% +$62.7K ﹤0.01% 4873
2023
Q1 		$42.3K Buy
+4,561
New +$47.4K ﹤0.01% 5252
2022
Q4 		– Sell
-310
Closed -$6K – 7460
2022
Q3 		$6K Sell
310
-120
-28% -$1.82K ﹤0.01% 5841
2022
Q2 		$6K Sell
430
-791
-65% -$13.1K ﹤0.01% 5930
2022
Q1 		$27K Sell
1,221
-2,047
-63% -$39K ﹤0.01% 5899
2021
Q4 		$55K Buy
+3,268
New +$58.4K ﹤0.01% 5927

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wells Fargo's AURA Position: Q1 2026 in Review

Wells Fargo reduced its Aura Biosciences (AURA) stake by 65% in Q1 2026, selling an estimated $184K and leaving 16,994 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5036.

Wells Fargo first reported a position in AURA in Q4 2021 and has held it in 17 quarters since. The position peaked at $267K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Wells Fargo held 16,994 shares of Aura Biosciences worth $114K as of Q1 2026.
  • Wells Fargo sold 32,059 Aura Biosciences shares in Q1 2026, an estimated $184K.
  • Aura Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5036 holding.
  • Wells Fargo first reported a position in Aura Biosciences in Q4 2021 and has held it in 17 quarters since.
  • Wells Fargo's Aura Biosciences position peaked at $267K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.